Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01703572
Title A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors OncoMed Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UC San Diego Moores Cancer Center La Jolla California 92093 United States Details
University of Colorado Hospital, Anschutz Cancer Pavilion Aurora Colorado 80045 United States Details
UF Health Davis Cancer Pavilion and Shands Med Plaza Gainesville Florida 32608 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198-7680 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198 United States Details
Cornell University Division of Hematology and Medical Oncology New York New York 10065 United States Details
NYU Clinical Cancer Center New York New York 97219 United States Details
University of Rochester Medical Center Rochester New York 14642 United States Details
Duke Cancer Institute Durham North Carolina 27710 United States Details
Sara Cannon Research Institute Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field